Stock seems to be very volatile going up or down a few %. This might be result of company instability and related poor management and bad strategy. But there could be another reason, managing to cause such stock price swings, so the founders, big investors and cronies can profit from these price swings. SEC may look closer at this manipulation.
Gilead has announced more than 100 person layoff coming, this time from the HQ location.
Streamlining ahead of a new administration, or as usual, a result of internal chaos and turmoil?
More layoffs would come in 2025.
Today the company announced laying off 170 employees. This was predictable and earlier posts indicated such possibility. Beware, this is the first round. More would come. Possibly you were told that your team would not be affected and then you suddenly learned about being on the list. This is the dreadful management style here, keeping you in the dark and throwing under the bus.
Time that this should happen to such management as well. Let's consider proposing names in this forum of the worst managers who should be gone asap. Btw is brinda staying or going? Or g and g? or h? You know who.
We all wonder how the new CEO would shape the company. Would he sweep out the incompetent, or internally networked? Who would be the replacements? Roche and Genentech people with experience mismatch? Some candidates may be attracted by location coming from some dull, backwater places. However, internal management changes are needed.
Very good candidates cannot be attracted considering future product portfolio prospects. Therefore, a new team may be as inefficient as the old one. All under the excuse of working on ultrarare diseases. Really rare, like the 3 hemophilia patients so far. The Gates Foundation is more appropriate to work on such scale projects.
Top management needs to be replaced, followed by incompetent middle level.
The top managers have been useless preoccupied with how to protect their positions and at the same time minimizing their responsibilities. They could not manage the parts of organization they were put in charge of.
But watch who will be coming. Roche-Genentech buddies or transition opportunists including international travelers. The CEO to be watched.
